NICU Antibiotics and Outcomes (NANO) Follow-up Study

NCT05977400 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

802

Enrollment

OTHER

Sponsor class

Conditions

Premature Birth
Antibiotics
Neurodevelopment

Interventions

DRUG: Ampicillin
DRUG: Gentamicin
DRUG: Placebo

Sponsor

Sharp HealthCare

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]